MORE ARTICLES YOU MAY LIKE
Jean Lycke | Addressing Unmet Medical Needs in Mucosal Disease: A Close-to-Market Innovation Approach
Recurrent Aphthous Stomatitis (RAS) is an oral condition characterized by one or several painful mucosal ulcers. RAS affects a large proportion of the population and has a point prevalence of approximately 2–3%, daily. The etiology remains unknown, and there is currently no curative treatment. Most patients experience recurring episodes over time, with each episode typically lasting up to a week. Here, we describe the development of a mucoadhesive patch which, when applied over a RAS ulcer, provides rapid pain relief. The patch is easy for patients to apply when symptoms begin and has the potential to be used as an over-the-counter product. The development of the Mucocort mucoadhesive patch is an example of a Close-to-Market innovation strategy that embraces simplicity within a complex healthcare system. By simplifying the product concept, the team has reduced the number of regulatory steps required before market approval. This MedTech/Pharma innovation model, known as the “4R” framework – Re-purposing, Re-formulation, Re-positioning, and Re-patenting – has guided the program from concept to commercialization. In addition to the biodegradable mucoadhesive patch developed for RAS ulcers, the team is extending the innovation concept to a mucoadhesive gel formulation for the prevention and treatment of chemotherapy-induced mucositis. This gel-based program is being commercialized separately through MucoShield.
The Translational Asian Agerelated Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care
Age-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older adults worldwide. In Asia, where populations are ageing rapidly, its impact is particularly profound. For many, the disease quietly erodes central vision, making everyday activities such as reading, driving, and recognising faces increasingly difficult. Against this backdrop, the Translational Asian Age-related Macular Degeneration Programme, or TAAP for short, has emerged as a bold and ambitious effort to confront the disease headon. Now in its second phase, TAAP-2 represents a significant evolution in both scientific scope and clinical ambition.
Professor Michael Yarus | How RNA Started the Conversation That Built Life
The genetic code stores the instructions for building proteins, yet how it first arose remains unclear. It likely did not appear fully formed, but instead emerged step by step from simple chemical interactions. In this study, a team led by Professor Michael Yarus at the University of Colorado Boulder shows how early ribonucleic acid (RNA) molecules could bind specific amino acids, creating the first coding relationships. These early interactions are then refined through evolutionary processes such as duplication and merging of partial codes. By combining the experimental data with computer simulations, the work provides a testable pathway from prebiotic chemistry to the modern genetic code.
Dr David Berry | Bridging the gap between Agriculture and Automation
As automation and controlled environments reshape modern farming, the need for technicians who understand both plant science and engineering is rapidly increasing. At Virginia Western Community College (VWCC) located in Roanoke, VA, Dr David Berry is leading a programme supported by the National Science Foundation (NSF) with the aim to merge agriculture with mechatronics, preparing students for the realities of emerging industries. A distinctive example of this approach is an automated hydroponics system designed by two industry-sponsored students, demonstrating how practical experience, interdisciplinary training and strong employer partnerships can create the skilled workforce required for the future of sustainable food production.